n-acetylneuraminic acid has been researched along with Autism Spectrum Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelsattar, HA; Ashaat, EA; Ashaat, NA; Bawady, SA; El-Bassyouni, HT; El-Hariri, HM; Elnaggar, W; Ganem, MMF; Mohamed, R; Sabry, S; Saleh, DA; Zaki, ME | 1 |
| Han, P; Hao, Y; Jiang, X; Liang, S; Wang, J; Wang, L; Wu, L; Yang, X | 1 |
2 other study(ies) available for n-acetylneuraminic acid and Autism Spectrum Disorder
| Article | Year |
|---|---|
Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder.
Topics: Autism Spectrum Disorder; Biomarkers; Child; Gangliosides; Humans; Immunoglobulin G; N-Acetylneuraminic Acid | 2023 |
Sialic acid and anti-ganglioside antibody levels in children with autism spectrum disorders.
Topics: Antibodies; Autism Spectrum Disorder; Child; Child, Preschool; Female; Gangliosidosis, GM1; Humans; Male; N-Acetylneuraminic Acid; ROC Curve; Severity of Illness Index | 2018 |